OLR1 and cerebral cavernous malformation: However, we found ox-LDL to be also significantly expressed in the plasma of CCM patients (Supplementary Table 2) indicating that higher LOX-1 levels in CCM patients might correlates with increased risk for atherosclerosis and vascular disorders.